Literature DB >> 19728517

Pemphigus: a brief review.

Richard W Groves1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19728517      PMCID： PMC4952511          DOI： 10.7861/clinmedicine.9-4-371

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  25 in total

Review 1.  Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem).

Authors:  Valeria Aoki; Robert C Millikan; Evandro A Rivitti; Gunter Hans-Filho; Donald P Eaton; Simon J P Warren; Ning Li; Julio Hilario-Vargas; Raymond G Hoffmann; Luis A Diaz
Journal:  J Investig Dermatol Symp Proc       Date:  2004-01

Review 2.  Paraneoplastic pemphigus.

Authors:  Grant J Anhalt
Journal:  J Investig Dermatol Symp Proc       Date:  2004-01

Review 3.  The immunogenetics of pemphigus vulgaris.

Authors:  Ephraim Gazit; Ron Loewenthal
Journal:  Autoimmun Rev       Date:  2005-01       Impact factor: 9.754

4.  Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.

Authors:  Jens Waschke; Paola Bruggeman; Werner Baumgartner; Detlef Zillikens; Detlev Drenckhahn
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

5.  Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire.

Authors:  S Brenner; E Tur; J Shapiro; V Ruocco; M D'Avino; E Ruocco; N Tsankov; S Vassileva; K Drenovska; P Brezoev; M A Barnadas; M J Gonzalez; G Anhalt; H Nousari; M Ramos-e-Silva; K T Pinto; M F Miranda; M R Silva
Journal:  Int J Dermatol       Date:  2001-09       Impact factor: 2.736

6.  The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.

Authors:  K E Harman; P T Seed; M J Gratian; B S Bhogal; S J Challacombe; M M Black
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

7.  Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3.

Authors:  K E Harman; M J Gratian; P T Seed; B S Bhogal; S J Challacombe; M M Black
Journal:  Clin Exp Dermatol       Date:  2000-05       Impact factor: 3.470

8.  Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.

Authors:  Leon F Mentink; Maria W Mackenzie; Gábor G Tóth; Marianne Laseur; Frank P G Lambert; Nic J G M Veeger; Giuseppe Cianchini; Milos D Pavlovic; Marcel F Jonkman
Journal:  Arch Dermatol       Date:  2006-05

Review 9.  Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.

Authors:  Ma Barnadas; E Roe; S Brunet; P Garcia; P Bergua; L Pimentel; L Puig; A Francia; R García; C Gelpí; J Sierra; P Coll; A Alomar
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-01       Impact factor: 6.166

10.  Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris.

Authors:  F Capon; J Bharkhada; N E Cochrane; N J Mortimer; J F Setterfield; S Reynaert; M M Black; R W Vaughan; R C Trembath; K E Harman
Journal:  Br J Dermatol       Date:  2006-01       Impact factor: 9.302
View more
  11 in total

1.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

2.  Desmosomal component expression in normal, dysplastic, and oral squamous cell carcinoma.

Authors:  Nagamani Narayana; Julie Gist; Tyler Smith; Daniel Tylka; Gavin Trogdon; James K Wahl
Journal:  Dermatol Res Pract       Date:  2010-03-18

3.  A 3'UTR polymorphism marks differential KLRG1 mRNA levels through disruption of a miR-584-5p binding site and associates with pemphigus foliaceus susceptibility.

Authors:  Gabriel A Cipolla; Jong Kook Park; Liana A de Oliveira; Sara Cristina Lobo-Alves; Rodrigo C de Almeida; Ticiana D J Farias; Débora de S Lemos; Danielle Malheiros; Robert M Lavker; Maria Luiza Petzl-Erler
Journal:  Biochim Biophys Acta       Date:  2016-07-14

4.  Evaluation of Vitamin D Status in Newly Diagnosed Pemphigus Vulgaris Patients.

Authors:  Mahnaz Zarei; Mohammad Hassan Javanbakht; Cheida Chams-Davatchi; Maryam Daneshpazhooh; Mohammad Reza Eshraghian; Hoda DE-Rakhshanian; Mahmoud Djalali
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

5.  Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated Protein Kinase Activation?

Authors:  Gabriel A Cipolla; Jong Kook Park; Robert M Lavker; Maria Luiza Petzl-Erler
Journal:  Front Immunol       Date:  2017-09-05       Impact factor: 7.561

6.  Advanced Diagnostic Techniques in Autoimmune Bullous Diseases.

Authors:  Anuradha Jindal; Raghavendra Rao; Balbir S Bhogal
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

Review 7.  Role of immune cells in the ocular manifestations of pemphigoid diseases.

Authors:  Tanima Bose
Journal:  Ther Adv Ophthalmol       Date:  2019-08-08

8.  Serum selenium, zinc, and copper in early diagnosed patients with pemphigus vulgaris.

Authors:  Mh Javanbakht; M Daneshpazhooh; C Chams-Davatchi; Mr Eshraghian; M Zarei; M Chamari; Djalali M
Journal:  Iran J Public Health       Date:  2012-05-31       Impact factor: 1.429

9.  Rituximab in the treatment of pemphigus vulgaris.

Authors:  Labib R Zakka; Shawn S Shetty; A Razzaque Ahmed
Journal:  Dermatol Ther (Heidelb)       Date:  2012-11-15

10.  Childhood Occurrence of Pemphigus.

Authors:  Raju U Patil; Rajesh T Anegundi; Kumar R Gujjar; K R Indushekar
Journal:  Int J Clin Pediatr Dent       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.